Establishing a New Standard
Aquablation therapy represents a paradigm shift in the surgical treatment of BPH. By addressing the compromise between safety and efficacy, it delivers effective, safe and durable outcomes that are consistent across all prostate sizes and shapes, regardless of surgeon experience.
Predictable Precision
The first and only image-guided, heat-free robotic therapy for the treatment of lower urinary tract symptoms (LUTS) due to BPH.
Predictable Precision
The first and only image-guided, heat-free robotic therapy for the treatment of lower urinary tract symptoms (LUTS) due to BPH.
Predictable Precision
The first and only image-guided, heat-free robotic therapy for the treatment of lower urinary tract symptoms (LUTS) due to BPH.
Better Science, Proven Data
Significant and growing body of clinical evidence supports the benefits and clinical advantages of Aquablation therapy.
Better Science, Proven Data
Significant and growing body of clinical evidence supports the benefits and clinical advantages of Aquablation therapy.
Better Science, Proven Data
Significant and growing body of clinical evidence supports the benefits and clinical advantages of Aquablation therapy.
Discover our most recent achievements, where to find us, and what industry publications have to say about us.
Press Releases
- October 21, 2021 PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021
- September 28, 2021 PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy
- September 21, 2021 PROCEPT BioRobotics Corporation Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Events
Discover our most recent achievements, where to find us, and what industry publications have to say about us.
Press Releases
- October 21, 2021 PROCEPT BioRobotics Corp. to Report Third Quarter 2021 Financial Results on November 4, 2021
- September 28, 2021 PROCEPT BioRobotics Corporation Announces Cigna Adds Aquablation Therapy to its Coverage Policy
- September 21, 2021 PROCEPT BioRobotics Corporation Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Events
Aquablation Therapy Resources
Aquablation Therapy
